DK1261705T3 - Fremgangsmåder og sammensætninger til screening ved hjælp af difteritoksinkonstruktioner - Google Patents
Fremgangsmåder og sammensætninger til screening ved hjælp af difteritoksinkonstruktionerInfo
- Publication number
- DK1261705T3 DK1261705T3 DK00993043T DK00993043T DK1261705T3 DK 1261705 T3 DK1261705 T3 DK 1261705T3 DK 00993043 T DK00993043 T DK 00993043T DK 00993043 T DK00993043 T DK 00993043T DK 1261705 T3 DK1261705 T3 DK 1261705T3
- Authority
- DK
- Denmark
- Prior art keywords
- screening
- methods
- diphtheria toxin
- compositions
- toxin constructs
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16518999P | 1999-11-12 | 1999-11-12 | |
PCT/US2000/031232 WO2001034806A2 (fr) | 1999-11-12 | 2000-11-13 | Procedes et compositions de depistage au moyen d'edifices de toxine de la diphterie |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1261705T3 true DK1261705T3 (da) | 2009-02-02 |
Family
ID=22597844
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00993043T DK1261705T3 (da) | 1999-11-12 | 2000-11-13 | Fremgangsmåder og sammensætninger til screening ved hjælp af difteritoksinkonstruktioner |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1261705B1 (fr) |
JP (1) | JP2003513670A (fr) |
AT (1) | ATE409227T1 (fr) |
AU (1) | AU2904401A (fr) |
CA (1) | CA2396626A1 (fr) |
DE (1) | DE60040348D1 (fr) |
DK (1) | DK1261705T3 (fr) |
WO (1) | WO2001034806A2 (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7060433B1 (en) * | 1999-11-12 | 2006-06-13 | Rigel Pharmaceuticals, Inc. | Methods and compositions for screening using diphtheria toxin constructs |
US7090976B2 (en) | 1999-11-10 | 2006-08-15 | Rigel Pharmaceuticals, Inc. | Methods and compositions comprising Renilla GFP |
DK1228233T3 (da) * | 1999-11-10 | 2007-05-14 | Rigel Pharmaceuticals Inc | Fremgangsmåder og sammensætninger omfattende grönfluorescerende proteiner (GFP) fra Renilla |
US20030170724A1 (en) | 2002-03-08 | 2003-09-11 | Anderson David C. | Methods of identifying target polypeptides |
WO2003075859A2 (fr) * | 2002-03-08 | 2003-09-18 | Rigel Pharmaceuticals, Inc. | Composes modulant des processus associes a la production d'ige, procedes et trousses permettant l'identification et l'utilisation desdits composes |
US7189523B2 (en) | 2002-07-16 | 2007-03-13 | Rigel Pharmaceuticals, Inc. | Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a B-cell associated protein |
KR20090075800A (ko) * | 2006-09-20 | 2009-07-09 | 재단법인 한국파스퇴르연구소 | 세포에서의 표적 단백질 후보의 발현을 검출 및/또는 정량하는 방법 및 소형 분자 모듈레이터의 표적 단백질을 동정하는 방법 |
KR101482187B1 (ko) * | 2013-01-14 | 2015-01-14 | (주)넥스젠바이오텍 | 녹색형광단백질―인간상피세포재생인자 융합단백질의 생산을 위한 유전자 컨스트럭트 및 이를 이용한 녹색형광단백질-인간상피세포재생인자 융합단백질의 생산방법 |
KR101661912B1 (ko) * | 2016-01-29 | 2016-10-04 | (주)넥스젠바이오텍 | 녹색형광단백질-인간 상피세포재생인자 융합단백질을 유효성분으로 포함하는 주름 개선 및 항노화 화장료 조성물 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU3724495A (en) * | 1994-09-13 | 1996-03-29 | Prizm Pharmaceuticals, Inc. | Conjugates of heparin-binding epidermal growth factor-like growth factor with targeted agents |
US7001733B1 (en) * | 1998-05-12 | 2006-02-21 | Rigel Pharmaceuticals, Inc. | Methods and compositions for screening for modulations of IgE synthesis, secretion and switch rearrangement |
-
2000
- 2000-11-13 AU AU29044/01A patent/AU2904401A/en not_active Abandoned
- 2000-11-13 DE DE60040348T patent/DE60040348D1/de not_active Expired - Lifetime
- 2000-11-13 EP EP00993043A patent/EP1261705B1/fr not_active Expired - Lifetime
- 2000-11-13 AT AT00993043T patent/ATE409227T1/de active
- 2000-11-13 CA CA002396626A patent/CA2396626A1/fr not_active Abandoned
- 2000-11-13 JP JP2001537502A patent/JP2003513670A/ja active Pending
- 2000-11-13 DK DK00993043T patent/DK1261705T3/da active
- 2000-11-13 WO PCT/US2000/031232 patent/WO2001034806A2/fr active Application Filing
Also Published As
Publication number | Publication date |
---|---|
ATE409227T1 (de) | 2008-10-15 |
AU2904401A (en) | 2001-06-06 |
CA2396626A1 (fr) | 2001-05-17 |
DE60040348D1 (de) | 2008-11-06 |
JP2003513670A (ja) | 2003-04-15 |
EP1261705A2 (fr) | 2002-12-04 |
WO2001034806A9 (fr) | 2002-07-04 |
EP1261705B1 (fr) | 2008-09-24 |
WO2001034806A2 (fr) | 2001-05-17 |
WO2001034806A3 (fr) | 2001-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE466072T1 (de) | Bandscheibe | |
DK1259547T3 (da) | Højpotente, rekombinante antistoffer og fremgangsmåde til fremstilling heraf | |
IS2508B (is) | Mótefni gegn ED-B hneppinu í fíbrónektíni, smíði þeirra og notkanir | |
PL1668001T3 (pl) | Podstawione heteroarylobenzofuranowe kwasy | |
ATE500323T1 (de) | Subtilisin-variante | |
BRPI0414599A (pt) | pirrol-indóis substituìdos | |
ATE271058T1 (de) | Mycophenol bisphosponatverbindungen | |
NO20041917L (no) | Spesifikke midler som binder humant angiopoietin-2 | |
BR0314814A (pt) | Variantes otimizadas de fc e métodos para sua geração | |
ZA200501054B (en) | Transplant acceptance inducing cells of monocytic origin and their preparation and use. | |
HK1046004A1 (en) | Recombinant gelatins | |
EA200701293A1 (ru) | Терапевтическая композиция фактора роста кератиноцитов | |
DE60013098D1 (de) | Zusammensetzung zur hautdesinfizierung | |
DK1261705T3 (da) | Fremgangsmåder og sammensætninger til screening ved hjælp af difteritoksinkonstruktioner | |
DK1519944T3 (da) | Fremgangsmåder til fremstilling af fibrinogen | |
ATE247130T1 (de) | Inhibitoren für den urokinaserezeptor | |
ZA978503B (en) | Vertebrate smoothened proteins | |
DK1446733T3 (da) | Glycosylphosphatidylinositol indeholdende polypeptider | |
BR0108187A (pt) | Moléculas trade e usos relacionados com as mesmas | |
DE60101364D1 (de) | Strahlteiler zur Reduktion von polarisationsabhängigen Effekten | |
DOP2002000329A (es) | Composicion solida | |
TW200519206A (en) | Methods for producing novel medaka and novel medaka | |
TW200635951A (en) | Specific binding agents of human angiopoietin-2 | |
MY155265A (en) | Anti-dual integrin antibodies, compositions, methods and uses | |
ES1047228Y (es) | Union de la esterilla al marco de las puertas. |